TNFSF10 and cancer: Novel anti-cancer agents include death receptor agonists such as tumor necrosis factor related apoptosis inducing ligand (TRAIL) [2,4], or drugs that target specific cell death pathways, such as Smac mimetics [5,6] or inhibitors of caspase activity [3,7].